The work of the Partnership is centered on the goal of improving health outcomes for pregnant women and their babies in West Virginia.
The essential source of information upon which the initiatives of the Partnership are based is obtained from the Key Informant Survey. The first Key Informant Survey was conducted in 2006 to gain input from medical, nursing and other individuals serving pregnant women and their babies in both rural and urban areas about their opinions regarding why West Virginia has one of the highest rates of infant mortality and low birth weight babies in the nation.Learn More
CDC Recommends COVID-19 Vaccines for Young ChildrenJune 22, 2022
HRSA Launches New Maternal Mental Health Hotline (HELP4MOMS)June 22, 2022
COVID-19 in Newborn Care: Initial Lessons from the PandemicMay 26, 2020
Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence SyndromeMay 5, 2020
CURRENT NEWS & EVENTS
Treatment Services for Pregnant Women with Substance Use DisordersLearn More
Improving Care for Newborns with Substance Exposure and Neonatal Abstinence Syndrome (NAS)
The West Virginia Perinatal Partnership seeks to provide a better understanding of the extent and cost of the problem of perinatal substance use and to help implement effective interventions to reduce the impact. With funding from the Claude W. Benedum Foundation, and in collaboration with the Department of Health and Human Resources and many other state partners, the Perinatal Partnership is implementing a Quality Improvement initiative aimed at improving the identification, diagnosis and treatment of substance exposed infants in West Virginia.
Improving the identification of Substance Exposed Infants in WV is presented by Sean Loudin, MD of Cabell Huntington Hospital, Stefan Maxwell, MD of CAMC’s Women and Children’s Hospital, and Collin John, MD of Ruby Memorial, West Virginia University.See the Presentation